Mount Sinai researchers receive NIH grant to compare new treatment options for sickle cell disease

The Mount Sinai Health System has received a $12,180,625 grant from the National Heart, Lung and Blood Institute to compare new treatment options for sickle cell disease and determine which work best for specific patients.

Significant earnings improvement in 2023; e-prescription is standard in Germany – Biotech Investments

DocMorris AG / Key word(s): Annual Results 21-March-2024 / 06:58 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is

March 22, 2024

Roche wins first approval for subcutaneous Tecentriq – Pharmaceutical Technology

Tecentriq is Roche’s second highest-grossing oncology drug, generating SFr1.8bn ($2.1bn) in H1 2023. Image Credit: Judith Linine / Shutterstock. Roche has beaten competitors to score

August 30, 2023

Radiopharmaceutical company Telix aims for $202M IPO

Amid booming interest in radiopharmaceuticals, Telix Pharmaceuticals is planning to become a publicly traded company in the US. The biotech, based in North Melbourne, Australia

June 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.